Skip to content

LFMD

LifeMD, Inc.

NASDAQ · Healthcare · Medical - Pharmaceuticals · US

$2.25
−3.85%
Ask drillr

Year over year

Reported trailing growth

Revenue
-16.7%
EBITDA
—
EBIT
—
EPS
—
Free cash flow
—
Operating cash flow
—

Forward estimates

Based on analyst estimates

Revenue
+15.9%
EBITDA
+124.5%
EPS
+73.9%

Three-year CAGR

Revenue
+17.7%
EBITDA
+77.2%
EBIT
+52.5%
Net income
+62.4%
EPS
+56.6%
Free cash flow
—

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026